Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.13
(-0.98%)
CNY 15.13
(-0.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.95 Billion CNY | 9.19% |
| 2022 | 448.25 Million CNY | -50.07% |
| 2021 | 3.42 Billion CNY | 48.39% |
| 2020 | 2.34 Billion CNY | 8.62% |
| 2019 | 2.22 Billion CNY | -24.21% |
| 2018 | 2.8 Billion CNY | 18.65% |
| 2017 | 2.39 Billion CNY | 21.05% |
| 2016 | 2.03 Billion CNY | -15.04% |
| 2015 | 2.35 Billion CNY | 6.46% |
| 2014 | 2.27 Billion CNY | 23.33% |
| 2013 | 1.77 Billion CNY | 39.55% |
| 2012 | 1.31 Billion CNY | 30.48% |
| 2011 | 978.15 Million CNY | 36.5% |
| 2010 | 728.62 Million CNY | 34.58% |
| 2009 | 511.1 Million CNY | 8.46% |
| 2008 | 502.5 Million CNY | 36.27% |
| 2007 | 370.67 Million CNY | -4.91% |
| 2006 | 390.83 Million CNY | 16.18% |
| 2005 | 335.5 Million CNY | 13.71% |
| 2004 | 295.05 Million CNY | 29.35% |
| 2003 | 228.1 Million CNY | 25.86% |
| 2002 | 181.23 Million CNY | 20.47% |
| 2001 | 150.44 Million CNY | 40.39% |
| 2000 | 107.15 Million CNY | 19.15% |
| 1999 | 89.93 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 214.16 Million CNY | -64.44% |
| 2024 Q1 | 410.76 Million CNY | 119.17% |
| 2024 Q2 | 639.33 Million CNY | 21.04% |
| 2023 Q3 | 447.16 Million CNY | -4.68% |
| 2023 Q1 | 447.78 Million CNY | 67.35% |
| 2023 Q2 | 469.13 Million CNY | 4.77% |
| 2023 FY | - CNY | 9.19% |
| 2023 Q4 | 254.37 Million CNY | -43.11% |
| 2022 Q2 | 151.28 Million CNY | -52.57% |
| 2022 FY | - CNY | -50.07% |
| 2022 Q4 | 267.57 Million CNY | -50.1% |
| 2022 Q3 | 536.24 Million CNY | 254.47% |
| 2022 Q1 | 318.94 Million CNY | -81.04% |
| 2021 Q3 | 246.62 Million CNY | -70.94% |
| 2021 Q2 | 848.6 Million CNY | 163.9% |
| 2021 Q1 | 321.55 Million CNY | 393.9% |
| 2021 FY | - CNY | 48.39% |
| 2021 Q4 | 1.68 Billion CNY | 581.99% |
| 2020 Q1 | 523.17 Million CNY | 498153.84% |
| 2020 Q3 | 644.44 Million CNY | 6.65% |
| 2020 Q4 | 65.1 Million CNY | -89.9% |
| 2020 Q2 | 604.28 Million CNY | 15.5% |
| 2020 FY | - CNY | 8.62% |
| 2019 FY | - CNY | -24.21% |
| 2019 Q3 | 469.94 Million CNY | -27.72% |
| 2019 Q4 | -105.04 Thousand CNY | -100.02% |
| 2019 Q1 | 718.4 Million CNY | 44.79% |
| 2019 Q2 | 650.21 Million CNY | -9.49% |
| 2018 Q4 | 496.15 Million CNY | -25.91% |
| 2018 FY | - CNY | 18.65% |
| 2018 Q3 | 669.67 Million CNY | -18.76% |
| 2018 Q2 | 824.34 Million CNY | 39.94% |
| 2018 Q1 | 589.06 Million CNY | 30.65% |
| 2017 Q4 | 450.88 Million CNY | -19.19% |
| 2017 FY | - CNY | 21.05% |
| 2017 Q3 | 557.95 Million CNY | -3.12% |
| 2017 Q1 | 515.19 Million CNY | 79.43% |
| 2017 Q2 | 575.91 Million CNY | 11.79% |
| 2016 Q1 | 421.55 Million CNY | 7.33% |
| 2016 FY | - CNY | -15.04% |
| 2016 Q4 | 287.11 Million CNY | -38.8% |
| 2016 Q3 | 469.14 Million CNY | -17.32% |
| 2016 Q2 | 567.41 Million CNY | 34.6% |
| 2015 Q4 | 392.75 Million CNY | -33.18% |
| 2015 Q1 | 502.07 Million CNY | 14.68% |
| 2015 FY | - CNY | 6.46% |
| 2015 Q2 | 649.69 Million CNY | 29.4% |
| 2015 Q3 | 587.81 Million CNY | -9.52% |
| 2014 Q3 | 588.45 Million CNY | -19.26% |
| 2014 Q2 | 728.85 Million CNY | 111.75% |
| 2014 FY | - CNY | 23.33% |
| 2014 Q4 | 437.78 Million CNY | -25.6% |
| 2014 Q1 | 344.2 Million CNY | -0.47% |
| 2013 Q3 | 433.95 Million CNY | -14.21% |
| 2013 Q1 | 331.05 Million CNY | 26.9% |
| 2013 FY | - CNY | 39.55% |
| 2013 Q4 | 345.83 Million CNY | -20.31% |
| 2013 Q2 | 505.82 Million CNY | 52.79% |
| 2012 FY | - CNY | 30.48% |
| 2012 Q4 | 260.86 Million CNY | -19.56% |
| 2012 Q2 | 320.67 Million CNY | 30.56% |
| 2012 Q1 | 245.61 Million CNY | -12.27% |
| 2012 Q3 | 324.29 Million CNY | 1.13% |
| 2011 Q1 | 139.45 Million CNY | -24.19% |
| 2011 FY | - CNY | 36.5% |
| 2011 Q2 | 353.09 Million CNY | 153.2% |
| 2011 Q4 | 279.97 Million CNY | 25.04% |
| 2011 Q3 | 223.9 Million CNY | -36.59% |
| 2010 Q2 | 168.62 Million CNY | 62.9% |
| 2010 Q3 | 170.04 Million CNY | 0.84% |
| 2010 Q4 | 183.94 Million CNY | 8.17% |
| 2010 FY | - CNY | 34.58% |
| 2010 Q1 | 103.51 Million CNY | -28.37% |
| 2009 Q3 | 123.74 Million CNY | 28.41% |
| 2009 FY | - CNY | 8.46% |
| 2009 Q4 | 144.5 Million CNY | 16.78% |
| 2009 Q2 | 96.36 Million CNY | 29.53% |
| 2009 Q1 | 74.39 Million CNY | -42.51% |
| 2008 Q4 | 129.4 Million CNY | 37.17% |
| 2008 Q1 | 70.21 Million CNY | -45.6% |
| 2008 FY | - CNY | 36.27% |
| 2008 Q2 | 98.02 Million CNY | 39.61% |
| 2008 Q3 | 94.33 Million CNY | -3.77% |
| 2007 FY | - CNY | -4.91% |
| 2007 Q2 | 70.94 Million CNY | 3.68% |
| 2007 Q1 | 68.42 Million CNY | -53.96% |
| 2007 Q3 | 55.54 Million CNY | -21.71% |
| 2007 Q4 | 129.08 Million CNY | 132.4% |
| 2006 Q3 | 85.1 Million CNY | -9.32% |
| 2006 Q4 | 148.61 Million CNY | 74.62% |
| 2006 Q1 | 65.24 Million CNY | -50.5% |
| 2006 FY | - CNY | 16.18% |
| 2006 Q2 | 93.85 Million CNY | 43.86% |
| 2005 FY | - CNY | 13.71% |
| 2005 Q1 | 52.77 Million CNY | -58.37% |
| 2005 Q4 | 131.79 Million CNY | 87.17% |
| 2005 Q3 | 70.41 Million CNY | -11.5% |
| 2005 Q2 | 79.56 Million CNY | 50.77% |
| 2004 Q1 | 39.2 Million CNY | -64.12% |
| 2004 Q3 | 69.02 Million CNY | 11.39% |
| 2004 Q4 | 126.75 Million CNY | 83.63% |
| 2004 FY | - CNY | 29.35% |
| 2004 Q2 | 61.96 Million CNY | 58.06% |
| 2003 FY | - CNY | 25.86% |
| 2003 Q4 | 109.26 Million CNY | 158.92% |
| 2003 Q3 | 42.2 Million CNY | -9.52% |
| 2003 Q1 | 31 Million CNY | -34.36% |
| 2003 Q2 | 46.64 Million CNY | 50.42% |
| 2002 Q1 | 27.05 Million CNY | 0.0% |
| 2002 Q2 | 45.09 Million CNY | 66.66% |
| 2002 FY | - CNY | 20.47% |
| 2002 Q3 | 38.28 Million CNY | -15.1% |
| 2002 Q4 | 47.23 Million CNY | 23.4% |
| 2001 FY | - CNY | 40.39% |
| 2000 FY | - CNY | 19.15% |
| 1999 FY | - CNY | 0.0% |